| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657894 | Clinics and Research in Hepatology and Gastroenterology | 2017 | 8 Pages |
Abstract
The individuals with NAFLD had a higher risk of 10-year CVD events than individuals without NAFLD, according to both ACC/AHA tool and primary care version of Framingham tool. A large proportion of NAFLD patients fulfill the criteria of statin therapy recommendation, suggesting that statin therapy could reduce 10-year CVD risk in NAFLD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nima Motamed, Behnam Rabiee, Hossein Poustchi, Babak Dehestani, Gholam Reza Hemasi, Mahmood Reza Khonsari, Mansooreh Maadi, Fatemeh Sima Saeedian, Farhad Zamani,